Print Page   |   Contact Us   |   Sign In   |   Register
Redefining Breast Cancer Treatment with Personalized Medicine
Tell a Friend About This EventTell a Friend

When: Friday, March 23, 2018
8:00 AM–12:30 PM
Where: Hilton Houston Plaza/Medical Center
6633 Travis Street
Houston, Texas 
United States
Contact: Phone: 860-434-1650

« Go to Upcoming Event List  


Program Overview
The goal of this summit is to improve treatment and care of patients with breast cancer by examining recent advances in pharmacogenomics, biomarker-based therapy, and precision medicine. Didactic sessions combined with practice-based learning, this summit covers the recent clinical data in the neoadjuvant, adjuvant, and metastatic settings for HR+ and HER2+ breast cancer and TNBC.

Target Audience
The target audience for this initiative includes oncologists, oncology APP's and nurses, and other health care professionals (HCPs) involved in managing patients with breast cancer.

Steering Committee
Komal Jhaveri, MD, FACP

Assistant Attending Physician 
Memorial Sloan Kettering Cancer Center 
Assistant Professor 
Weill Cornell Medical College

Heather L. McArthur, MD, MPH 
Medical Director, Breast Oncology
Cedars-Sinai Medical Center

Rashmi K. Murthy, MD, MBE 
Assistant Professor
Department of Breast Medical Oncology
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center

Accreditation Statement 
The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
Physicians: The France Foundation designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Maintenance of Certification: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4 MOC point(s) in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point(s) equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Commercial Support Acknowledgment 
This activity is supported by an educational grant from Celgene, Genentech, Lilly, Merck and Novartis.